Abstract Details
|
Jan A. Martin, MD
(University of Washington/Seattle Children's Hospital)
PRESENTER |
Dr. Martin has nothing to disclose. |
| No disclosure on file | |
| Craig A. Press, MD, PhD (Children's Hospital of Philadelphia) | Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH. |
| Ricka Messer, MD (Children'S Hospital Colorado) | The institution of Dr. Messer has received research support from Ultragenyx Pharmaceutical Inc. Dr. Messer has a non-compensated relationship as a Chair of the Pediatric Neurology Specialty Steering Board with Epic that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Messer has a non-compensated relationship as a Member of the Âé¶¹´«Ã½Ó³» Quality Informatics Subcommittee with Âé¶¹´«Ã½Ó³» that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |
| Megan M. Barry, MD (Lurie Children's Hospital of Chicago) | Dr. Barry has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file |